Legend Biotech Corp (LEGN) Long-Term Deferred Tax (2019)

Legend Biotech (LEGN) has disclosed Long-Term Deferred Tax for 1 consecutive years, with $22.8 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Long-Term Deferred Tax changed N/A year-over-year to $22.8 million, compared with a TTM value of $22.8 million through Dec 2021, changed N/A, and an annual FY2021 reading of $22.8 million, changed N/A over the prior year.
  • Long-Term Deferred Tax was $22.8 million for Q4 2021 at Legend Biotech.
  • Across five years, Long-Term Deferred Tax topped out at $22.8 million in Q4 2021 and bottomed at $22.8 million in Q4 2021.